Lysimachos obtained his PhD from the University of Edinburgh where he worked on systems neurobiology in health and disease, focusing on research comparing the mammalian and Drosophila synapses. Because of his academic background, he has a keen interest in central nervous system diseases such as Parkinson’s Disease. After completing his PhD, he obtained an extensive industry experience planning, managing and implementing CRO projects and also managing the R&D department of Brainwave-Discovery Ltd. There he developed a number of screening assays using Drosophila. These assays have applications in the fields of drug toxicity screening, drug discovery and neurodegeneration. He has been involved in the development, proof-of-concept testing and scale-up of the screening technology used at Parkure from the first day. Lysimachos is interested in bringing together innovative and established scientific findings to form fast and efficient high-throughput screening solutions with applications in fields where these features are key, such as the drug discovery industry. Moreover, he is very interested in ethical approaches, and is driven to apply these solutions to solve big problems in order to make the biggest positive impact possible. Lysimachos obtained his PhD from the University of Edinburgh where he worked on systems neurobiology in health and disease, focusing on research comparing the mammalian and Drosophila synapses. Because of his academic background, he has a keen interest in central nervous system diseases such as Parkinson’s Disease. After completing his PhD, he obtained an extensive industry experience planning, managing and implementing CRO projects and also managing the R&D department of Brainwave-Discovery Ltd. There he developed a number of screening assays using Drosophila. These assays have applications in the fields of drug toxicity screening, drug discovery and neurodegeneration. He has been involved in the development, proof-of-concept testing and scale-up of the screening technology used at Parkure from the first day. Lysimachos is interested in bringing together innovative and established scientific findings to form fast and efficient high-throughput screening solutions with applications in fields where these features are key, such as the drug discovery industry. Moreover, he is very interested in ethical approaches, and is driven to apply these solutions to solve big problems in order to make the biggest positive impact possible.

fermentation